Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Low Dose Atazanavir/r Versus Standard Dose Atazanavir/r (LASA)

This study has been completed.
Kirby Institute
National Health Security Office, Thailand
Information provided by (Responsible Party):
The HIV Netherlands Australia Thailand Research Collaboration Identifier:
First received: June 4, 2010
Last updated: August 17, 2016
Last verified: August 2016